Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Figure S3 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
Home
Publications
Supplementary Figure S3 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
Supplementary Figure S3 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
Authors:
HX
Huaiyuan Xu
Huaiyuan Xu
JH
Jinxin Hu
Jinxin Hu
YZ
Yun Zhang
Yun Zhang
AZ
Aihua Zhuang
Aihua Zhuang
YZ
Yingchun Zhang
Yingchun Zhang
JL
Jibin Li
Jibin Li
HW
Hao Wu
Hao Wu
GS
Guohui Song
Guohui Song
CD
Chuanquan Deng
Chuanquan Deng
HC
Hongmin Chen
Hongmin Chen
WC
Weiqing Chen
Weiqing Chen
CD
Chuangzhong Deng
Chuangzhong Deng
See more
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
1 June 2026
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1078-0432.32530922
Abstract
Figure S3. Distribution of PRO-CTCAE scores at successive time points during active therapy and maximum score post-baseline without and with baseline adjustment
Keywords
CHEMOTHERAPY
CLINICAL TRIAL RESULTS
PHASE III CLINICAL TRIALS
SARCOMAS
SOFT-TISSUE SARCOMA
Related articles
Scroll to top